Try our beta test site
18 studies found for:    pulmonary alveolar proteinosis
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP)
Condition: Hereditary Pulmonary Alveolar Proteinosis
Intervention: Drug: Leukine
2 Recruiting Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)
Condition: Autoimmune Pulmonary Alveolar Proteinosis
Intervention: Drug: GM-CSF
3 Completed Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial
Condition: Pulmonary Alveolar Proteinosis
Intervention: Other: Retrospective Chart Review
4 Unknown  Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis
Conditions: Pulmonary Alveolar Proteinosis;   Primary Disease
Intervention: Drug: rituximab
5 Unknown  Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP)
Condition: Pulmonary Alveolar Proteinosis
Interventions: Drug: GM-CSF [Leukine (Sargramostim)];   Procedure: WLL
6 Recruiting Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Condition: Autoimmune Pulmonary Alveolar Proteinosis
Interventions: Drug: molgramostim;   Drug: placebo
7 Terminated GM-CSF in Patients With Pulmonary Alveolar Proteinosis
Condition: Pulmonary Alveolar Proteinosis
Intervention: Drug: GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)
8 Recruiting A National Registry For Pulmonary Alveolar Proteinosis
Condition: Pulmonary Alveolar Proteinosis
Intervention:
9 Active, not recruiting Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan
Condition: Pulmonary Alveolar Proteinosis, Autoimmune
Interventions: Drug: Sargramostim;   Drug: Placebo
10 Not yet recruiting Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis
Condition: Autoimmune Pulmonary Alveolar Proteinosis
Intervention: Drug: Sargramostim
11 Unknown  Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
Condition: Pulmonary Alveolar Proteinosis
Interventions: Drug: rhGM-CSF;   Procedure: Whole Lung Lavage(WLL)
12 Recruiting Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT
Condition: Pulmonary Alveolar Proteinosis
Intervention:
13 Completed SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study
Condition: Pulmonary Alveolar Proteinosis, Autoimmune
Intervention: Drug: Sargramostim
14 Recruiting Rituximab for Anti-cytokine Autoantibody-Associated Diseases
Conditions: Anticytokine Autoantibody-Associated Diseases;   Disseminated Non-Tuberculous Mycobacteria;   Chronic Mucocutaneous Candidiasis;   Pulmonary Alveolar Proteinosis (PAP)
Intervention: Drug: Rituximab/Rituxan
15 Completed Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects
Conditions: Pulmonary Alveolar Proteinosis;   Bronchiectasis;   Cystic Fibrosis;   Acute Respiratory Distress Syndrome
Interventions: Drug: Molgramostim;   Drug: Placebo
16 Recruiting European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Conditions: Lung Diseases, Interstitial;   Pulmonary Alveolar Proteinosis;   Pulmonary Eosinophilia;   Pulmonary Fibrosis;   Respiratory Distress Syndrome, Newborn;   Child
Intervention:
17 Recruiting Natural History Study of GATA2 Deficiency and Related Disorders
Conditions: Myelodysplasia;   Monocytopenia;   B Cell Lymphopenia;   NK Cell Deficiency;   Warts
Intervention:
18 Recruiting Epidemiology of Surfactant Protein-B Deficiency
Conditions: Lung Diseases;   Respiratory Distress Syndrome, Newborn;   Pulmonary Surfactants
Intervention:

Study has passed its completion date and status has not been verified in more than two years.